Selected research
Industry Research
Circadian Rhythm Sleep Treatment Industry Research Report 2026
Market perspective
The global Circadian Rhythm Sleep Treatment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Circadian Rhythm Sleep Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Circadian Rhythm Sleep Treatment market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Circadian Rhythm Sleep Treatment market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Circadian Rhythm Sleep Treatment include By-Health, GNC, Jameison, Koninklijke Philips, Luminette, Natrol, Nature Made (Pharmavite), NBTY and PEGASI, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Circadian Rhythm Sleep Treatment market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Circadian Rhythm Sleep Treatment.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Circadian Rhythm Sleep Treatment Market by Company
By-Health
GNC
Jameison
Koninklijke Philips
Luminette
Natrol
Nature Made (Pharmavite)
NBTY
PEGASI
Sleepace
Takeda Pharmaceutical
Vicks (Procter & Gamble)
Teva Pharmaceuticals
Circadian Rhythm Sleep Treatment Segment by Type
Drug Therapy
Light Therapy
Circadian Rhythm Sleep Treatment Segment by Application
Delayed Sleep Phase Syndrome (DSPS)
Advanced Sleep Phase Syndrome (ASPS)
Irregular Sleep-Wake Disorder (ISWD)
Others
Circadian Rhythm Sleep Treatment Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Circadian Rhythm Sleep Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Circadian Rhythm Sleep Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Circadian Rhythm Sleep Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Circadian Rhythm Sleep Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Drug Therapy
- Light Therapy
Applications
- Delayed Sleep Phase Syndrome (DSPS)
- Advanced Sleep Phase Syndrome (ASPS)
- Irregular Sleep-Wake Disorder (ISWD)
- Others
Companies covered
- By-Health
- GNC
- Jameison
- Koninklijke Philips
- Luminette
- Natrol
- Nature Made (Pharmavite)
- NBTY
- PEGASI
- Sleepace
- Takeda Pharmaceutical
- Vicks (Procter & Gamble)
- Teva Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Circadian Rhythm Sleep Treatment by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Drug Therapy
- 2.2.3 Light Therapy
- 2.3 Circadian Rhythm Sleep Treatment by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Delayed Sleep Phase Syndrome (DSPS)
- 2.3.3 Advanced Sleep Phase Syndrome (ASPS)
- 2.3.4 Irregular Sleep-Wake Disorder (ISWD)
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Circadian Rhythm Sleep Treatment Breakdown Data by Type
- 3.1 Global Circadian Rhythm Sleep Treatment Historic Market Size by Type (2021-2026)
- 3.2 Global Circadian Rhythm Sleep Treatment Forecasted Market Size by Type (2027-2032)
4 Circadian Rhythm Sleep Treatment Breakdown Data by Application
- 4.1 Global Circadian Rhythm Sleep Treatment Historic Market Size by Application (2021-2026)
- 4.2 Global Circadian Rhythm Sleep Treatment Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Circadian Rhythm Sleep Treatment Market Perspective (2021-2032)
- 5.2 Global Circadian Rhythm Sleep Treatment Growth Trends by Region
- 5.2.1 Global Circadian Rhythm Sleep Treatment Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Circadian Rhythm Sleep Treatment Historic Market Size by Region (2021-2026)
- 5.2.3 Circadian Rhythm Sleep Treatment Forecasted Market Size by Region (2027-2032)
- 5.3 Circadian Rhythm Sleep Treatment Market Dynamics
- 5.3.1 Circadian Rhythm Sleep Treatment Industry Trends
- 5.3.2 Circadian Rhythm Sleep Treatment Market Drivers
- 5.3.3 Circadian Rhythm Sleep Treatment Market Challenges
- 5.3.4 Circadian Rhythm Sleep Treatment Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Circadian Rhythm Sleep Treatment Players by Revenue
- 6.1.1 Global Top Circadian Rhythm Sleep Treatment Players by Revenue (2021-2026)
- 6.1.2 Global Circadian Rhythm Sleep Treatment Revenue Market Share by Players (2021-2026)
- 6.2 Global Circadian Rhythm Sleep Treatment Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Circadian Rhythm Sleep Treatment Head Office and Area Served
- 6.4 Global Circadian Rhythm Sleep Treatment Players, Product Type & Application
- 6.5 Global Circadian Rhythm Sleep Treatment Manufacturers Established Date
- 6.6 Global Circadian Rhythm Sleep Treatment Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Circadian Rhythm Sleep Treatment Market Size (2021-2032)
- 7.2 North America Circadian Rhythm Sleep Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Circadian Rhythm Sleep Treatment Market Size by Country (2021-2026)
- 7.4 North America Circadian Rhythm Sleep Treatment Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Circadian Rhythm Sleep Treatment Market Size (2021-2032)
- 8.2 Europe Circadian Rhythm Sleep Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Circadian Rhythm Sleep Treatment Market Size by Country (2021-2026)
- 8.4 Europe Circadian Rhythm Sleep Treatment Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Circadian Rhythm Sleep Treatment Market Size (2021-2032)
- 9.2 Asia-Pacific Circadian Rhythm Sleep Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Circadian Rhythm Sleep Treatment Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Circadian Rhythm Sleep Treatment Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Circadian Rhythm Sleep Treatment Market Size (2021-2032)
- 10.2 South America Circadian Rhythm Sleep Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Circadian Rhythm Sleep Treatment Market Size by Country (2021-2026)
- 10.4 South America Circadian Rhythm Sleep Treatment Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Circadian Rhythm Sleep Treatment Market Size (2021-2032)
- 11.2 Middle East & Africa Circadian Rhythm Sleep Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Circadian Rhythm Sleep Treatment Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Circadian Rhythm Sleep Treatment Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 By-Health
- 12.1.1 By-Health Company Information
- 12.1.2 By-Health Business Overview
- 12.1.3 By-Health Revenue in Circadian Rhythm Sleep Treatment Business (2021-2026)
- 12.1.4 By-Health Circadian Rhythm Sleep Treatment Product Portfolio
- 12.1.5 By-Health Recent Developments
- 12.2 GNC
- 12.2.1 GNC Company Information
- 12.2.2 GNC Business Overview
- 12.2.3 GNC Revenue in Circadian Rhythm Sleep Treatment Business (2021-2026)
- 12.2.4 GNC Circadian Rhythm Sleep Treatment Product Portfolio
- 12.2.5 GNC Recent Developments
- 12.3 Jameison
- 12.3.1 Jameison Company Information
- 12.3.2 Jameison Business Overview
- 12.3.3 Jameison Revenue in Circadian Rhythm Sleep Treatment Business (2021-2026)
- 12.3.4 Jameison Circadian Rhythm Sleep Treatment Product Portfolio
- 12.3.5 Jameison Recent Developments
- 12.4 Koninklijke Philips
- 12.4.1 Koninklijke Philips Company Information
- 12.4.2 Koninklijke Philips Business Overview
- 12.4.3 Koninklijke Philips Revenue in Circadian Rhythm Sleep Treatment Business (2021-2026)
- 12.4.4 Koninklijke Philips Circadian Rhythm Sleep Treatment Product Portfolio
- 12.4.5 Koninklijke Philips Recent Developments
- 12.5 Luminette
- 12.5.1 Luminette Company Information
- 12.5.2 Luminette Business Overview
- 12.5.3 Luminette Revenue in Circadian Rhythm Sleep Treatment Business (2021-2026)
- 12.5.4 Luminette Circadian Rhythm Sleep Treatment Product Portfolio
- 12.5.5 Luminette Recent Developments
- 12.6 Natrol
- 12.6.1 Natrol Company Information
- 12.6.2 Natrol Business Overview
- 12.6.3 Natrol Revenue in Circadian Rhythm Sleep Treatment Business (2021-2026)
- 12.6.4 Natrol Circadian Rhythm Sleep Treatment Product Portfolio
- 12.6.5 Natrol Recent Developments
- 12.7 Nature Made (Pharmavite)
- 12.7.1 Nature Made (Pharmavite) Company Information
- 12.7.2 Nature Made (Pharmavite) Business Overview
- 12.7.3 Nature Made (Pharmavite) Revenue in Circadian Rhythm Sleep Treatment Business (2021-2026)
- 12.7.4 Nature Made (Pharmavite) Circadian Rhythm Sleep Treatment Product Portfolio
- 12.7.5 Nature Made (Pharmavite) Recent Developments
- 12.8 NBTY
- 12.8.1 NBTY Company Information
- 12.8.2 NBTY Business Overview
- 12.8.3 NBTY Revenue in Circadian Rhythm Sleep Treatment Business (2021-2026)
- 12.8.4 NBTY Circadian Rhythm Sleep Treatment Product Portfolio
- 12.8.5 NBTY Recent Developments
- 12.9 PEGASI
- 12.9.1 PEGASI Company Information
- 12.9.2 PEGASI Business Overview
- 12.9.3 PEGASI Revenue in Circadian Rhythm Sleep Treatment Business (2021-2026)
- 12.9.4 PEGASI Circadian Rhythm Sleep Treatment Product Portfolio
- 12.9.5 PEGASI Recent Developments
- 12.10 Sleepace
- 12.10.1 Sleepace Company Information
- 12.10.2 Sleepace Business Overview
- 12.10.3 Sleepace Revenue in Circadian Rhythm Sleep Treatment Business (2021-2026)
- 12.10.4 Sleepace Circadian Rhythm Sleep Treatment Product Portfolio
- 12.10.5 Sleepace Recent Developments
- 12.11 Takeda Pharmaceutical
- 12.11.1 Takeda Pharmaceutical Company Information
- 12.11.2 Takeda Pharmaceutical Business Overview
- 12.11.3 Takeda Pharmaceutical Revenue in Circadian Rhythm Sleep Treatment Business (2021-2026)
- 12.11.4 Takeda Pharmaceutical Circadian Rhythm Sleep Treatment Product Portfolio
- 12.11.5 Takeda Pharmaceutical Recent Developments
- 12.12 Vicks (Procter & Gamble)
- 12.12.1 Vicks (Procter & Gamble) Company Information
- 12.12.2 Vicks (Procter & Gamble) Business Overview
- 12.12.3 Vicks (Procter & Gamble) Revenue in Circadian Rhythm Sleep Treatment Business (2021-2026)
- 12.12.4 Vicks (Procter & Gamble) Circadian Rhythm Sleep Treatment Product Portfolio
- 12.12.5 Vicks (Procter & Gamble) Recent Developments
- 12.13 Teva Pharmaceuticals
- 12.13.1 Teva Pharmaceuticals Company Information
- 12.13.2 Teva Pharmaceuticals Business Overview
- 12.13.3 Teva Pharmaceuticals Revenue in Circadian Rhythm Sleep Treatment Business (2021-2026)
- 12.13.4 Teva Pharmaceuticals Circadian Rhythm Sleep Treatment Product Portfolio
- 12.13.5 Teva Pharmaceuticals Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst